End-binding protein 1 stimulates paclitaxel sensitivity in breast cancer by promoting its actions toward microtubule assembly and stability

Youguang Luo, Dengwen Li, Jie Ran, Bing Yan, Jie Chen, Xin Dong, Zhu Liu, Ruming Liu, Jun Zhou, Min Liu

PDF(1650 KB)
PDF(1650 KB)
Protein Cell ›› 2014, Vol. 5 ›› Issue (6) : 469-479. DOI: 10.1007/s13238-014-0053-0
RESEARCH ARTICLE
RESEARCH ARTICLE

End-binding protein 1 stimulates paclitaxel sensitivity in breast cancer by promoting its actions toward microtubule assembly and stability

Author information +
History +

Abstract

Paclitaxel is a microtubule-targeting agent widely used for the treatment of many solid tumors. However, patients show variable sensitivity to this drug, and effective diagnostic tests predicting drug sensitivity remain to be investigated. Herein, we show that the expression of end-binding protein 1 (EB1), a regulator of microtubule dynamics involved in multiple cellular activities, in breast tumor tissues correlates with the pathological response of tumors to paclitaxel-based chemotherapy. In vitro cell proliferation assays reveal that EB1 stimulates paclitaxel sensitivity in breast cancer cell lines. Our data further demonstrate that EB1 increases the activity of paclitaxel to cause mitotic arrest and apoptosis in cancer cells. In addition, microtubule binding affinity analysis and polymerization/depolymerization assays show that EB1 enhances paclitaxel binding to microtubules and stimulates the ability of paclitaxel to promote microtubule assembly and stabilization. These findings thus reveal EB1 as a critical regulator of paclitaxel sensitivity and have important implications in breast cancer chemotherapy.

Keywords

breast cancer / paclitaxel / microtubule / cell proliferation / apoptosis / end-binding protein 1 / chemotherapy

Cite this article

Download citation ▾
Youguang Luo, Dengwen Li, Jie Ran, Bing Yan, Jie Chen, Xin Dong, Zhu Liu, Ruming Liu, Jun Zhou, Min Liu. End-binding protein 1 stimulates paclitaxel sensitivity in breast cancer by promoting its actions toward microtubule assembly and stability. Protein Cell, 2014, 5(6): 469‒479 https://doi.org/10.1007/s13238-014-0053-0

References

[1]
Akhmanova A, Steinmetz MO (2008) Tracking the ends: a dynamic protein network controls the fate of microtubule tips. Nat Rev Mol Cell Biol9: 309322
CrossRef Google scholar
[2]
Amos LA, Schlieper D (2005) Microtubules and maps. Adv Protein Chem71: 257298
CrossRef Google scholar
[3]
Asakawa K, Toda T (2006) Cooperation of EB1-Mal3 and the Bub1 spindle checkpoint. Cell Cycle5: 2730
CrossRef Google scholar
[4]
Bieling P, Laan L, Schek H, Munteanu EL, Sandblad L, Dogterom M, Brunner D, Surrey T (2007) Reconstitution of a microtubule plusend tracking system in vitro. Nature450: 11001105
CrossRef Google scholar
[5]
Blagosklonny MV, Demidenko ZN, Giovino M, Szynal C, Donskoy E, Herrmann RA, Barry JJ, Whalen AM (2006) Cytostatic activity of paclitaxel in coronary artery smooth muscle cells is mediated through transient mitotic arrest followed by permanent postmitotic arrest: comparison with cancer cells. Cell Cycle5: 15741579
CrossRef Google scholar
[6]
Bu W, Su LK (2001) Regulation of microtubule assembly by human EB1 family proteins. Oncogene20: 31853192
CrossRef Google scholar
[7]
Dong X, Liu F, Sun L, Liu M, Li D, Su D, Zhu Z, Dong JT, Fu L, Zhou J (2010) Oncogenic function of microtubule end-binding protein 1 in breast cancer. J Pathol220: 361369
[8]
Dragestein KA, van Cappellen WA, van Haren J, Tsibidis GD, Akhmanova A, Knoch TA, Grosveld F, Galjart N (2008) Dynamic behavior of GFP-CLIP-170 reveals fast protein turnover on microtubule plus ends. J Cell Biol180: 729737
CrossRef Google scholar
[9]
Dumontet C, Jordan MA (2010) Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov9: 790803
CrossRef Google scholar
[10]
Galjart N (2010) Plus-end-tracking proteins and their interactions at microtubule ends. Curr Biol20: R528R537
[11]
Honnappa S, Gouveia SM, Weisbrich A, Damberger FF, Bhavesh NS, Jawhari H, Grigoriev I, van Rijssel FJ, Buey RM, Lawera A (2009) An EB1-binding motif acts as a microtubule tip localization signal. Cell138: 366376
CrossRef Google scholar
[12]
Huo L, Li D, Sun L, Liu M, Shi X, Sun X, Li J, Dong B, Dong X, Zhou J (2011) Tat acetylation regulates its actions on microtubule dynamics and apoptosis in T lymphocytes. J Pathol223: 2836
CrossRef Google scholar
[13]
Ikui AE, Yang CP, Matsumoto T, Horwitz SB (2005) Low concentrations of taxol cause mitotic delay followed by premature dissociation of p55CDC from Mad2 and BubR1 and abrogation of the spindle checkpoint, leading to aneuploidy. Cell Cycle4: 13851388
CrossRef Google scholar
[14]
Jiang K, Akhmanova A (2011) Microtubule tip-interacting proteins: a view from both ends. Curr Opin Cell Biol23: 94101
CrossRef Google scholar
[15]
Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer4: 253265
CrossRef Google scholar
[16]
Komlodi-Pasztor E, Sackett D, Wilkerson J, Fojo T (2011) Mitosis is not a key target of microtubule agents in patient tumors. Nat Rev Clin Oncol8: 244250
CrossRef Google scholar
[17]
Kronja I, Kruljac-Letunic A, Caudron-Herger M, Bieling P, Karsenti E (2009) XMAP215-EB1 interaction is required for proper spindle assembly and chromosome segregation in Xenopus egg extract. Mol Biol Cell20: 26842696
CrossRef Google scholar
[18]
Li D, Xie S, Ren Y, Huo L, Gao J, Cui D, Liu M, Zhou J (2011) Microtubule-associated deacetylase HDAC6 promotes angiogenesis by regulating cell migration in an EB1-dependent manner. Protein Cell2: 150160
CrossRef Google scholar
[19]
Liu M, Yu H, Huo L, Liu J, Li M, Zhou J (2008) Validating the mitotic kinesin Eg5 as a therapeutic target in pancreatic cancer cells and tumor xenografts using a specific inhibitor. Biochem Pharmacol76: 169178
CrossRef Google scholar
[20]
Mohan R, Katrukha EA, Doodhi H, Smal I, Meijering E, Kapitein LC, Steinmetz MO, Akhmanova A (2013) End-binding proteins sensitize microtubules to the action of microtubule-targeting agents. Proc Natl Acad Sci USA110: 89008905
CrossRef Google scholar
[21]
Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell10: 515527
CrossRef Google scholar
[22]
Quinn JE, James CR, Stewart GE, Mulligan JM, White P, Chang GK, Mullan PB, Johnston PG, Wilson RH, Harkin DP (2007) BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy. Clin Cancer Res13: 74137420
CrossRef Google scholar
[23]
Rouzier R, Rajan R, Wagner P, Hess KR, Gold DL, Stec J, Ayers M, Ross JS, Zhang P, Buchholz TA (2005) Microtubuleassociated protein tau: a marker of paclitaxel sensitivity in breast cancer. Proc Natl Acad Sci USA102: 83158320
CrossRef Google scholar
[24]
Schuyler SC, Pellman D (2001) Microtubule plus-end-tracking proteins: The end is just the beginning. Cell105: 421424
CrossRef Google scholar
[25]
Strickland LI, Wen Y, Gundersen GG, Burgess DR (2005) Interaction between EB1 and p150glued is required for anaphase astral microtubule elongation and stimulation of cytokinesis. Curr Biol15: 22492255
CrossRef Google scholar
[26]
Sun L, Gao J, Dong X, Liu M, Li D, Shi X, Dong JT, Lu X, Liu C, Zhou J (2008) EB1 promotes Aurora-B kinase activity through blocking its inactivation by protein phosphatase 2A. Proc Natl Acad Sci USA105: 71537158
CrossRef Google scholar
[27]
Sun X, Shi X, Liu M, Li D, Zhang L, Liu X, Zhou J (2011) Mdp3 is a novel microtubule-binding protein that regulates microtubule assembly and stability. Cell Cycle10: 39293937
CrossRef Google scholar
[28]
Sun X, Li D, Yang Y, Ren Y, Li J, Wang Z, Dong B, Liu M, Zhou J (2012) Microtubule-binding protein CLIP-170 is a mediator of paclitaxel sensitivity. J Pathol226: 666673
CrossRef Google scholar
[29]
Sun X, Li F, Dong B, Suo S, Liu M, Li D, Zhou J (2013) Regulation of tumor angiogenesis by the microtubule-binding protein CLIP-170. Protein Cell4: 266276
CrossRef Google scholar
[30]
Tommasi S, Mangia A, Lacalamita R, Bellizzi A, Fedele V, Chiriatti A, Thomssen C, Kendzierski N, Latorre A, Lorusso V (2007) Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins. Int J Cancer120: 20782085
CrossRef Google scholar
[31]
Veitia R, David S, Barbier P, Vantard M, Gounon P, Bissery MC, Fellous A (2000) Proteolysis of microtubule associated protein 2 and sensitivity of pancreatic tumours to docetaxel. Brit J Cancer83: 544549
CrossRef Google scholar
[32]
Vichai V, Kirtikara K (2006) Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc1: 11121116
CrossRef Google scholar
[33]
Vitre B, Coquelle FM, Heichette C, Garnier C, Chretien D, Arnal I (2008) EB1 regulates microtubule dynamics and tubulin sheet closure in vitro. Nat Cell Biol10: 415421
CrossRef Google scholar
[34]
Wagner P, Wang B, Clark E, Lee H, Rouzier R, Pusztai L (2005) Microtubule associated protein (MAP)-tau: a novel mediator of paclitaxel sensitivity in vitro and in vivo. Cell Cycle4: 11491152
CrossRef Google scholar
[35]
Wang H, Liu B, Zhang C, Peng G, Liu M, Li D, Gu F, Chen Q, Dong JT, Fu L (2009) Parkin regulates paclitaxel sensitivity in breast cancer via a microtubule-dependent mechanism. J Pathol218: 7685
CrossRef Google scholar
[36]
Wen Y, Eng CH, Schmoranzer J, Cabrera-Poch N, Morris EJS, Chen M, Wallar BJ, Alberts AS, Gundersen GG (2004) EB1 and APC bind to mDia to stabilize microtubules downstream of Rho and promote cell migration. Nat Cell Biol6: 820830
CrossRef Google scholar
[37]
Zovko S, Abrahams JP, Koster AJ, Galjart N, Mommaas AM (2008) Microtubule plus-end conformations and dynamics in the periphery of interphase mouse fibroblasts. Mol Biol Cell19: 31383146
CrossRef Google scholar

RIGHTS & PERMISSIONS

2014 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
AI Summary AI Mindmap
PDF(1650 KB)

Accesses

Citations

Detail

Sections
Recommended

/